Cantor Fitzgerald Starts Cleveland BioLabs (CBLI) at Buy
Tweet Send to a Friend
Cantor Fitzgerald initiated coverage on Cleveland BioLabs (NASDAQ: CBLI) with a Buy rating and a price target of $4.00.
This article: 101 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 101 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE